Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALBUS: Albumin in Surgical Septic Shock
NCT07212582Phase 3Not yet recruiting
- Sponsor
- Mahidol University
- Start
- Dec 2025
- Primary completion
- Dec 2029
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of albumin (human) in septic shock, sponsored by Mahidol University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
albumin (human)
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07212582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07212582.